Annual Drug Patent Expirations for KIMYRSA
Kimyrsa is a drug marketed by Melinta Therap and is included in one NDA. It is available from one supplier.
The generic ingredient in KIMYRSA is oritavancin diphosphate. One supplier is listed for this compound. Additional details are available on the oritavancin diphosphate profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
